{"gene":"BHLHE40","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":1997,"finding":"BHLHE40 (Stra13) encodes a bHLH protein that represses activated transcription through an alpha-helix rich C-terminal domain, in part by interaction with general factors of the basal transcription machinery, and does not bind the canonical E-box or N-box motifs recognized by other bHLH proteins.","method":"Transient transfection reporter assays, protein-protein interaction studies, overexpression in P19 cells","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 — original cloning paper with functional domain characterization and multiple orthogonal assays; foundational study","pmids":["9284045"],"is_preprint":false},{"year":2001,"finding":"Stra13 (BHLHE40) interacts physically with the bHLHZip protein USF through its C-terminal repression domain and the DNA-binding domain of USF; co-expression causes mutual functional antagonism, with USF abrogating Stra13-mediated repression and Stra13 inhibiting USF DNA binding and transactivation.","method":"Yeast two-hybrid screen, co-immunoprecipitation, reporter assays, EMSA","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction confirmed by multiple methods including Y2H and functional co-expression assays","pmids":["11498797"],"is_preprint":false},{"year":2001,"finding":"BHLHE40 (Stra13) is required for proper CD4+ T cell activation and elimination of activated lymphocytes; Stra13-deficient mice develop autoimmune disease with accumulation of activated T and B cells, indicating a key role in lymphocyte homeostasis.","method":"Stra13-knockout mouse model, in vivo lymphocyte phenotyping, immunology assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype; highly cited foundational study","pmids":["11668339"],"is_preprint":false},{"year":2002,"finding":"HIF-1α and HIF-1β directly bind functional hypoxia response elements (HREs) in the BHLHE40 (DEC1) promoter region (-524 to -401), activating its transcription in response to hypoxia or CoCl2.","method":"Luciferase reporter assays, EMSA showing HIF-1α/β binding to HRE, deletion/mutation analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct HIF-1 binding to promoter demonstrated by EMSA and mutational dissection","pmids":["12354771"],"is_preprint":false},{"year":2002,"finding":"DEC1 (BHLHE40) promotes chondrocyte differentiation when overexpressed in ATDC5 cells, antagonizes the inhibitory action of PTH/PTHrP, and induces expression of type II collagen, Indian hedgehog, and Runx2.","method":"Forced expression in ATDC5 cells and bone marrow mesenchymal stem cells, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function with defined molecular targets but single-lab study","pmids":["12384505"],"is_preprint":false},{"year":2003,"finding":"DEC1 (BHLHE40) directly binds an E-box motif in the proximal promoter of DEC2 and represses DEC2 transcription; DNA-binding-defective DEC1 mutants lose this repressive activity.","method":"Reporter assays with deletion/site-directed mutants, stable transfectants with tetracycline-inducible DEC1","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct DNA binding shown with mutational validation and functional consequence","pmids":["12624110"],"is_preprint":false},{"year":2003,"finding":"BHLHE40 (Stra13) circadian expression in peripheral tissues is driven by the CLOCK-BMAL1 heterodimer via a response element in the proximal promoter; Stra13 in turn represses its own CLOCK-BMAL1-driven transcription (autorepression), and CRY1 strongly represses CLOCK-BMAL1-dependent Stra13 activation.","method":"Reporter assays, microarray gene expression in Stra13-/- mice liver, genetic knockout","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including genetic KO and functional promoter analysis","pmids":["14581485"],"is_preprint":false},{"year":2004,"finding":"DEC1 (BHLHE40) represses the mPer1 promoter through direct E-box binding rather than through protein-protein interaction with Bmal1; DNA-binding mutants of DEC1 that retain Bmal1 interaction cannot repress the mPer1 promoter.","method":"Reporter assays, yeast two-hybrid, EMSA, mutational analysis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — direct mechanistic dissection of DNA binding vs. protein interaction using mutants","pmids":["15193144"],"is_preprint":false},{"year":2004,"finding":"STRA13 (BHLHE40) interacts with phosphorylated (active) STAT3α and STAT3β via its HLH and C-terminal regions; STRA13 can activate transcription from STAT-dependent elements and modulates the transcriptional outcome of STAT3 on the Fas promoter.","method":"Yeast two-hybrid, co-immunoprecipitation, luciferase reporter assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction identified by Y2H and confirmed by Co-IP with functional reporter assays","pmids":["15223310"],"is_preprint":false},{"year":2005,"finding":"STRA13 (BHLHE40) interacts with MSP58 via its basic domain (with MSP58's FHA domain required), and complex formation protects both proteins from proteasome-mediated degradation; together they synergistically co-operate in STRA13 promoter-driven transcription repression.","method":"Yeast two-hybrid, Co-IP, phospho-peptide mapping, protein half-life assays, reporter assays","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods but single lab","pmids":["15719173"],"is_preprint":false},{"year":2006,"finding":"STRA13 (BHLHE40) represses STAT1 transcription through a mechanism requiring its C-terminal trans-activation domain which binds HDAC1; this HDAC-dependent mechanism also results in repression of STAT1 target genes (MHC antigen-presenting genes, CASP1) under hypoxia via VHL/HIF-1 activation.","method":"Luciferase reporter assays with deletion/site-directed mutants, ChIP, TSA inhibition","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including ChIP and TSA validation of HDAC mechanism","pmids":["16878149"],"is_preprint":false},{"year":2006,"finding":"DEC1 (BHLHE40) transactivates the survivin promoter through two Sp1 sites, and DEC1 protein is detected at the survivin promoter by EMSA and ChIP, establishing survivin as a direct transcriptional target.","method":"Reporter assays with Sp1 site mutants, EMSA, ChIP","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — direct promoter binding demonstrated by EMSA and ChIP with mutational validation","pmids":["16462771"],"is_preprint":false},{"year":2007,"finding":"DEC1 (BHLHE40) is a direct transcriptional target of the p53 family; p53 family proteins bind and activate the DEC1 promoter, and DEC1 overexpression induces G1 arrest and premature senescence independently of p21.","method":"cDNA microarray, luciferase reporter assays, ChIP showing p53 binding to DEC1 promoter, siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct p53 binding to DEC1 promoter shown by ChIP, with functional senescence phenotype","pmids":["18025081"],"is_preprint":false},{"year":2007,"finding":"Stra13 (BHLHE40) physically interacts with p53 in vitro and prevents Mdm2-mediated ubiquitination and nuclear export of p53, thereby stabilizing p53 levels to promote ionizing-radiation-induced apoptosis; Stra13-deficient thymocytes show reduced p53, Puma, and Noxa expression after irradiation.","method":"Stra13-/- mouse model, in vitro interaction assay, ubiquitination assay, gene expression","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution of interaction with functional validation in KO cells","pmids":["17347673"],"is_preprint":false},{"year":2007,"finding":"Stra13 (BHLHE40) modulates satellite cell activation by antagonizing Notch signaling; Stra13-/- primary myoblasts show enhanced Notch activity, increased proliferation, and defective differentiation, and inhibition of Notch signaling rescues the regeneration defect of Stra13-/- mice.","method":"Stra13 knockout mouse model, in vitro Notch pathway reporter assays, pharmacological Notch inhibition rescue","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — epistasis established by genetic KO and pharmacological rescue","pmids":["17502421"],"is_preprint":false},{"year":2007,"finding":"DEC1 (BHLHE40) is induced by TGF-β signaling in mammary carcinoma cells and promotes cell survival; knockdown of DEC1 abrogates TGF-β-promoted cell survival, and a dominant-negative DEC1 mutant prevents lung and liver metastasis in vivo.","method":"Microarray, kinase inhibitor treatment, dominant-negative overexpression, in vivo metastasis model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — in vivo and in vitro evidence with multiple mechanistic interventions","pmids":["17942899"],"is_preprint":false},{"year":2008,"finding":"BHLHE40 (BHLHB2) binds a specific sequence within Bdnf promoter 4 and mediates transcriptional repression; NMDA receptor activation reduces BHLHB2 occupancy at promoter 4, correlating with de-repressed BDNF exon 4 expression; Bhlhb2-/- mice show increased hippocampal BDNF exon 4 mRNA.","method":"EMSA, ChIP in hippocampal neurons, Bhlhb2 knockout mice","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — direct DNA binding by EMSA and ChIP confirmed in vivo by KO phenotype","pmids":["18234890"],"is_preprint":false},{"year":2008,"finding":"TGF-β/activin signaling resets the circadian clock through SMAD3-dependent immediate-early induction of Dec1 (BHLHE40); intraperitoneal TGF-β injection in wild-type but not Dec1-deficient mice produces phase-shifts in peripheral clock gene expression, establishing Dec1 as an essential mediator of this non-light resetting pathway.","method":"ALK inhibitor/activator treatment, SMAD3 phosphorylation assays, Dec1-/- mouse model, in vivo clock gene expression","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in KO mice with in vivo clock resetting phenotype; high impact study","pmids":["19029909"],"is_preprint":false},{"year":2008,"finding":"DEC1/STRA13 and DEC2 repress SREBP-1c by competing with SREBP-1c for binding to the E-box in the SREBP-1c promoter and/or by protein-protein interaction with SREBP-1c; DEC2 initiates acute hypoxic repression while DEC1 substitutes during prolonged hypoxia.","method":"Reporter assays, siRNA knockdown, protein-protein interaction assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — two mechanisms demonstrated (DNA competition and protein interaction) with siRNA validation","pmids":["18838394"],"is_preprint":false},{"year":2008,"finding":"DEC1 (BHLHB2) and DEC2 transcriptionally repress MLH1 by directly binding E-box-like motifs in the MLH1 promoter; repression is abolished by the HDAC inhibitor trichostatin A, indicating a histone deacetylase-dependent mechanism.","method":"Reporter assays, site-directed mutagenesis, EMSA, ChIP, TSA inhibition","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding confirmed by EMSA/ChIP with HDAC-mechanism validation","pmids":["18345027"],"is_preprint":false},{"year":2008,"finding":"BHLHB2/DEC1 (BHLHE40) suppresses ChREBP-mediated lipogenic gene expression by binding to carbohydrate response elements (ChoRE) in the Fasn, Lpk, and Bhlhb2 promoters, forming a negative feedback loop with ChREBP.","method":"ChIP in rat hepatocytes, reporter deletion assays, overexpression studies","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct binding; single lab","pmids":["18602890"],"is_preprint":false},{"year":2009,"finding":"Bhlhe40 binds to adjacent E-boxes (E1-box) on the PGC-1α core promoter and represses MyoD-mediated transactivation by sequestering the co-activator P/CAF from MyoD; P/CAF can relieve Bhlhe40-mediated repression in a dose-dependent manner.","method":"EMSA, ChIP, co-immunoprecipitation, reporter assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — direct DNA binding by EMSA/ChIP, interaction mechanism by Co-IP, functional rescue by P/CAF","pmids":["19522704"],"is_preprint":false},{"year":2010,"finding":"Dec1 (BHLHE40) interacts physically with the transcription factor Runx1 in regulatory T cells; the Dec1/Runx1 complex binds regulatory elements of the Il-2rα (CD25) locus, upregulating CD25 expression and supporting Treg homeostasis.","method":"Co-immunoprecipitation, ChIP at Il-2rα locus, enforced Dec1 expression in thymocytes","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct complex binding to target locus demonstrated by ChIP; interaction confirmed by Co-IP","pmids":["21057086"],"is_preprint":false},{"year":2011,"finding":"DEC1 (BHLHE40) directly binds a DEC-response element in the cyclin D1 promoter and represses cyclin D1 expression, linking DEC1 to G1/S cell cycle control.","method":"Reporter assays with cyclin D1 promoter mutants, ChIP confirming direct binding","journal":"The Journal of pathology","confidence":"High","confidence_rationale":"Tier 1-2 — direct promoter binding demonstrated by ChIP and mutational reporter analysis","pmids":["21506129"],"is_preprint":false},{"year":2011,"finding":"DEC1 (BHLHE40) physically interacts with HDAC2 and increases binding of DEC1 to the ΔNp63 promoter when HDAC2 is knocked down; DEC1 represses ΔNp63 expression and thereby modulates keratinocyte differentiation.","method":"Co-immunoprecipitation, ChIP, siRNA knockdown, reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — Co-IP demonstrates physical interaction; ChIP shows promoter occupancy with functional phenotype","pmids":["21317427"],"is_preprint":false},{"year":2011,"finding":"SUMOylation of DEC1 (BHLHE40) at K159 and K279 stabilizes the protein by inhibiting ubiquitination, promotes its nuclear retention, and potentiates repression of CLOCK/BMAL1-mediated transcriptional activity through recruitment of HDAC1.","method":"SUMO modification assay in COS-7/MCF-7 cells, site-directed mutagenesis of SUMO acceptor lysines, ubiquitination assay, reporter assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — SUMOylation sites identified by mutagenesis, mechanism linked to HDAC1 recruitment and protein stability","pmids":["21829689"],"is_preprint":false},{"year":2012,"finding":"SUMOylation of Stra13 (BHLHE40) at K159 and K279 potentiates transcriptional repression of cyclin D1 and G1 cell cycle arrest by enabling association with the co-repressor HDAC1; SUMO-site mutants localize normally to the nucleus but lose HDAC1 interaction and growth-suppressive activity.","method":"SUMO-site mutagenesis, co-immunoprecipitation with HDAC1, reporter assays, cell cycle analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic link between SUMOylation, HDAC1 recruitment, and cell cycle arrest established by mutagenesis and Co-IP","pmids":["22905217"],"is_preprint":false},{"year":2012,"finding":"DEC1 (BHLHE40) represses PPARγ2 transcription by physically interacting with C/EBPβ already bound to the PPARγ2 promoter; DEC1 occupancy is accompanied by increased HDAC1 recruitment and reduced histone acetylation at the promoter.","method":"Co-immunoprecipitation, ChIP, reporter assays, adipogenic differentiation assay","journal":"Molecules and cells","confidence":"High","confidence_rationale":"Tier 2 — Co-IP and ChIP show interaction and promoter occupancy; mechanism linked to HDAC1","pmids":["22610404"],"is_preprint":false},{"year":2014,"finding":"Bhlhe40 (BHLHE40) is required cell-intrinsically in T cells to positively regulate GM-CSF production and negatively regulate IL-10 production; Bhlhe40-deficient mice are resistant to EAE and IL-10 receptor blockade restores susceptibility.","method":"Bhlhe40-/- mouse model, T cell adoptive transfer, cytokine ELISA, IL-10R blockade rescue","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with cytokine rescue; in vivo and in vitro corroboration","pmids":["24699451"],"is_preprint":false},{"year":2014,"finding":"DEC1 (BHLHE40) coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73: DEC1 activates TAp73 by recruiting HDAC8 to the TAp73 promoter, while repressing ΔNp73 through a distinct promoter mechanism.","method":"Co-immunoprecipitation of DEC1-HDAC8, ChIP showing HDAC8 recruitment to TAp73 promoter, reporter assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — protein interaction and differential promoter binding demonstrated by Co-IP and ChIP","pmids":["24404147"],"is_preprint":false},{"year":2014,"finding":"DEC1 (BHLHE40) protein stability is regulated by a dual ubiquitin-protease mechanism: SCFβTrCP ubiquitin ligase (in cooperation with CK1) targets DEC1 for proteasomal degradation during unperturbed cell cycles, while ATM/ATR-dependent DNA damage induces rapid DEC1 stabilization via the USP17 deubiquitylase, which binds and deubiquitylates DEC1.","method":"Ubiquitination assays, protein half-life measurements, Co-IP of SCFβTrCP and USP17 with DEC1, degradation-resistant mutant expression","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro and cell-based ubiquitination/deubiquitination assays with writer (SCFβTrCP/CK1) and eraser (USP17) identified","pmids":["25202122"],"is_preprint":false},{"year":2014,"finding":"Bhlhe40 (BHLHE40) functions as a cofactor of T-bet (Tbx21) on the Ifng locus in iNKT cells; Bhlhe40 accumulates at the T-box region of the Ifng locus and promotes histone H3-K9 acetylation of the Ifng locus in a T-bet-dependent manner, enhancing IFN-γ production.","method":"ChIP at Ifng locus, Bhlhe40-/- mouse model, Ifng promoter reporter assays, histone acetylation analysis","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrates locus occupancy and histone modification; T-bet dependency shown in KO","pmids":["27226296"],"is_preprint":false},{"year":2015,"finding":"BHLHE40 and BHLHE41 suppress EMT effectors SNAI1, SNAI2, and TWIST1; BHLHE40/41 compete with the transcription factor SP1 for DNA binding at the TWIST1 promoter to regulate its basal transcriptional activity.","method":"Reporter assays with TWIST1 promoter, competition binding assays, in vitro invasion assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — reporter and competition assays; single lab","pmids":["26391953"],"is_preprint":false},{"year":2015,"finding":"Bhlhe40 (BHLHE40) binds directly to the PGC-1α C-terminal activation domain and co-occupies PGC-1α target gene promoters/enhancers, repressing PGC-1α transactivational activity by recruiting HDACs and preventing relief of PGC-1α intramolecular repression.","method":"Co-immunoprecipitation of Bhlhe40-PGC-1α, ChIP at target promoters, HDAC recruitment assays, siRNA knockdown","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — direct protein interaction and co-occupancy shown by Co-IP and ChIP with mechanistic follow-up","pmids":["25963661"],"is_preprint":false},{"year":2015,"finding":"Hypoxia induces Bhlhe40 (BHLHE40) expression via a p53-dependent but HIF1α-independent pathway; Bhlhe40 binds proximal E-boxes of the Myog promoter and reduces MyoD binding affinity and transcriptional activity, thereby inhibiting myogenic differentiation under hypoxia.","method":"Microarray analysis, ChIP at Myog promoter, Bhlhe40 overexpression/knockdown, p53-dependent pathway analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct promoter binding by ChIP, mechanistic pathway placement, rescue experiment","pmids":["26468276"],"is_preprint":false},{"year":2015,"finding":"DEC1 (BHLHE40) directly binds the E-box of the LKB1 promoter, repressing LKB1 expression; reduced LKB1 activity leads to decreased AMPK activity, establishing a DEC1→LKB1→AMPK regulatory axis.","method":"ChIP at LKB1 promoter E-box, DEC1 knockdown/overexpression, AMPK activity assays, DEC1 basic-domain mutants","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct binding; functional epistasis via LKB1 shown; single lab","pmids":["26498531"],"is_preprint":false},{"year":2016,"finding":"IL-1β induces Bhlhe40 (BHLHE40) expression in Th17 cells, defining a PTX-IL-1β-Bhlhe40 pathway; Bhlhe40 expression identifies encephalitogenic Th cells producing IFN-γ, IL-17A, and GM-CSF, and Bhlhe40-deficient Th1 and Th17 cells are nonencephalitogenic in adoptive transfer EAE.","method":"Bhlhe40 reporter mice, adoptive transfer EAE, IL-1β stimulation, cytokine analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic reporter, adoptive transfer epistasis, and cytokine pathway placement","pmids":["26834156"],"is_preprint":false},{"year":2018,"finding":"Bhlhe40 (BHLHE40) positively regulates IFN-γ production and negatively regulates IL-10 production in Th1 cells; Bhlhe40-mediated IFN-γ production is independent of T-bet regulation; in vivo, Bhlhe40-deficient mice succumb to Toxoplasma gondii infection and IL-10 signaling blockade rescues them.","method":"Conditional Bhlhe40 deletion in T cells, in vitro Th1 polarization, in vivo T. gondii infection model, IL-10R blockade","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with in vivo rescue experiment establishes pathway position","pmids":["29773643"],"is_preprint":false},{"year":2018,"finding":"BHLHE40 promotes HBEGF transcription by blocking DNA binding of HDAC1 and HDAC2 at the HBEGF promoter; HBEGF secreted through exosomes promotes breast cancer cell survival and migration.","method":"ChIP showing BHLHE40 at HBEGF promoter, co-immunoprecipitation of BHLHE40 with HDAC1/2, CRISPR KO, exosome analysis","journal":"Breast cancer research","confidence":"High","confidence_rationale":"Tier 2 — ChIP and Co-IP with CRISPR validation and functional cellular assays","pmids":["30285805"],"is_preprint":false},{"year":2018,"finding":"Bhlhe40 (BHLHE40) negatively regulates PGC-1α gene expression and the function and biogenesis of peroxisomes and mitochondria in myogenic cells; Bhlhe40 knockdown increases peroxisome number/activity but reduces mitochondrial efficiency, while overexpression of the PGC-1α-interacting domain of Bhlhe40 differentially regulates the two organelles.","method":"siRNA knockdown, overexpression, peroxisome/mitochondria counting and activity assays, gene expression profiling","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular phenotype with organelle-level readouts; single lab","pmids":["30391825"],"is_preprint":false},{"year":2018,"finding":"DEC1 (BHLHE40) and CLOCK bind E-boxes in the ATP1B1 (Na+/K+-ATPase β1 subunit) promoter; CLOCK:BMAL1 activates ATP1B1 transcription while DEC1 suppresses this transactivation, and Dec1-deficient mice show enhanced Atp1b1 expression and reduced blood pressure.","method":"ChIP and ChIP-on-chip at ATP1B1 promoter, luciferase reporter assays, Dec1-/- and Clock-mutant mice","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 — direct promoter binding by ChIP confirmed by KO phenotype in vivo","pmids":["30012868"],"is_preprint":false},{"year":2019,"finding":"Bhlhe40 (BHLHE40) is required for tissue-resident memory CD8+ T cell (Trm) and tumor-infiltrating lymphocyte (TIL) development and polyfunctionality; mechanistically, Bhlhe40 sustains mitochondrial fitness and a functional epigenetic state; local PD-1 signaling inhibits TIL Bhlhe40 expression and Bhlhe40 is critical for TIL reinvigoration following anti-PD-L1 blockade.","method":"Bhlhe40 KO mouse model, mitochondrial function assays, ATAC-seq epigenetic profiling, anti-PD-L1 treatment","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (metabolic, epigenetic, genetic KO, checkpoint blockade) in single high-impact study","pmids":["31533057"],"is_preprint":false},{"year":2019,"finding":"Bhlhe40 (BHLHE40) is required cell-intrinsically for the self-renewal and proliferation (but not polarization) of large peritoneal macrophages (LPMs); Bhlhe40 represses c-Maf and Mafb expression and directly promotes expression of cell cycle genes; Bhlhe40 binds genomic sites co-occupied by PU.1 as well as unique sites at Maf and cell-cycle loci.","method":"Bhlhe40 conditional KO, competitive reconstitution, ChIP-seq in LPMs, IL-4 proliferation assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP-seq plus genetic KO with defined proliferation phenotype","pmids":["31061528"],"is_preprint":false},{"year":2019,"finding":"Bhlhe40 and Bhlhe41 directly repress expression of lineage-inappropriate genes in alveolar macrophages (AMs) to maintain AM identity and self-renewal; genome-wide Bhlhe40 DNA binding analysis showed direct repression of non-AM signature genes.","method":"Bhlhe40/41 double-KO mouse model, gene expression analysis, ChIP-seq/genome-wide binding characterization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genome-wide binding data combined with functional KO phenotype","pmids":["31414712"],"is_preprint":false},{"year":2019,"finding":"BHLHE40 expression in H. pylori-infected gastric epithelial cells is induced via the cagA-ERK pathway; BHLHE40 translocates to the nucleus and binds p-STAT3 (Tyr705); the BHLHE40-p-STAT3 complex increases CXCL12 expression, fostering CD4+ T cell infiltration.","method":"Co-immunoprecipitation of BHLHE40 and p-STAT3, ChIP at CXCL12 promoter, ERK pathway inhibitors","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and ChIP demonstrate interaction and functional outcome; single lab","pmids":["31914631"],"is_preprint":false},{"year":2020,"finding":"BHLHE40 (and BHLHE41) act as negative feedback regulators of TFEB transcriptional activity; high, sustained nuclear TFEB induces BHLHE40/41 expression, and BHLHE40/41 counter-regulate TFEB target genes, particularly genes relevant to lysosomal cell death.","method":"Genome-wide CRISPR screen, TFEB activation assays, gene expression analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR screen plus functional validation; single study","pmids":["33176151"],"is_preprint":false},{"year":2020,"finding":"BHLHE40 is required in T cells for a TH2 cell transcriptional program during helminth infection, positively regulating GM-CSF (Csf2) and IL-5 production; combined loss of GM-CSF and IL-5 signaling impairs helminth protection.","method":"Bhlhe40 conditional KO in T cells, helminth infection model, cytokine gene expression analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo conditional KO with cytokine redundancy demonstrated; single lab","pmids":["31900338"],"is_preprint":false},{"year":2021,"finding":"Bhlhe40 (BHLHE40) is a cell-intrinsic negative regulator of the germinal center (GC) reaction; in activated CD4 T cells it restrains proliferation limiting TFH numbers, while in B cells it selectively restricts generation of earliest GC B cells; Bhlhe40-deficient mice develop B cell lymphoma characterized by GC B-like cells.","method":"Bhlhe40-/- mouse model, flow cytometry, adoptive transfer, longitudinal lymphoma monitoring","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined cellular and disease phenotype","pmids":["34919144"],"is_preprint":false},{"year":2022,"finding":"BHLHE40 directly transcriptionally regulates TAN-1 (pro-tumour neutrophil) marker genes in pancreatic cancer, downstream of hypoxia and endoplasmic reticulum stress; direct transcriptional regulation demonstrated by ChIP assay.","method":"Single-cell RNA-seq, ChIP assay, BHLHE40 overexpression in dHL-60 cells","journal":"Gut","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct regulation; functional overexpression data; single study","pmids":["35688610"],"is_preprint":false},{"year":2022,"finding":"BHLHE40 regulates T cell-dependent anti-tumor immunity and immune checkpoint therapy (ICT) efficacy; anti-PD-1 and anti-CTLA-4 upregulate BHLHE40 in tumor antigen-specific T cells; BHLHE40-deficient T cells show dysregulated NF-κB signaling, IFNγ response, and altered chemokine/granzyme expression; BHLHE40 is required for ICT-driven macrophage polarization.","method":"Bhlhe40-/- mouse model, single-cell RNA-seq, in vivo tumor models with ICT","journal":"Cancer immunology research","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KO combined with scRNA-seq; single study","pmids":["35181783"],"is_preprint":false},{"year":2023,"finding":"BHLHE40 regulates SREBF1 transcription as a classic transcription factor and also physically links the enhancer and promoter regions of SREBF1; the BHLHE40-SREBF1-stearoyl-CoA desaturase axis protects pancreatic cancer cells from ferroptosis by reducing lipid peroxidation.","method":"ChIP-seq, RNA-seq, Hi-C/chromosome conformation capture assays, BHLHE40 KO/overexpression","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 1-2 — multi-omics including ChIP-seq and 3D genome conformation data with functional ferroptosis readout","pmids":["38064101"],"is_preprint":false},{"year":2023,"finding":"BHLHE40 (BHLHE40) in vitro CRISPR screen identified it as a regulator of CD8+ T cell exhaustion differentiation; in vitro and in vivo validation showed BHLHE40 regulates the differentiation checkpoint between progenitor and intermediate exhausted T cell subsets.","method":"In vitro chronic stimulation model, genome-wide CRISPR screen, in vivo validation","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR screen with in vivo validation; single study","pmids":["37595022"],"is_preprint":false},{"year":2023,"finding":"BHLHE40 represses MAFA expression by attenuating the binding of PDX1 to the Mafa enhancer region, thereby suppressing insulin secretion in hypoxic β-cells; BHLHE40 deficiency in hypoxic MIN6 cells or ob/ob β-cells reverses insulin secretion defects.","method":"BHLHE40 KO/overexpression in MIN6 cells and ob/ob mice, ChIP at Mafa enhancer, MAFA re-expression rescue","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP shows mechanism (reduced PDX1 binding), genetic rescue with MAFA re-expression, in vivo ob/ob model","pmids":["37341148"],"is_preprint":false},{"year":2024,"finding":"Loss of BHLHE40/41 in macrophages results in increased expression of DLAM (disease-associated macrophage) genes involved in cholesterol clearance and lysosomal processing, increased cholesterol efflux and storage, and increased lysosomal mass and degradative capacity, identifying BHLHE40/41 as transcriptional repressors of this activation state.","method":"BHLHE40/41 KO in iPSC-derived microglia and THP-1 macrophages; mouse Bhlhe40/41 KO; gene regulatory network reconstruction from scRNA-seq data","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple cell models (iPSC-microglia, THP-1, mouse KO) with functional lipid/lysosomal readouts","pmids":["38448474"],"is_preprint":false}],"current_model":"BHLHE40 is a bHLH transcriptional repressor (and context-dependent activator) that competes with CLOCK:BMAL1 and other bHLH factors for E-box binding to regulate circadian rhythms, hypoxia responses, and immune cell function; its activity is modulated by SUMOylation (which recruits HDAC1/2 and stabilizes the protein), ubiquitin-mediated proteolysis (SCFβTrCP/CK1 for degradation, USP17 for stabilization after DNA damage), and protein-protein interactions with STAT3, Runx1, PGC-1α, T-bet, USF, MSP58, and HDAC1/2/8, collectively enabling it to control cytokine production (GM-CSF, IFN-γ, IL-10), macrophage identity/proliferation, T cell exhaustion checkpoints, mitochondrial fitness, lipid metabolism, and cellular senescence."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing that BHLHE40 is a bHLH transcriptional repressor that acts through its α-helix-rich C-terminal domain rather than through canonical E-box binding defined the gene's foundational molecular identity.","evidence":"Transient transfection reporter assays and protein-protein interaction studies in P19 cells","pmids":["9284045"],"confidence":"High","gaps":["No endogenous target genes identified","Mechanism of repression (direct vs. cofactor-mediated) unresolved","In vivo relevance not tested"]},{"year":2001,"claim":"Demonstrating that BHLHE40 physically antagonizes USF via its C-terminal domain and that Bhlhe40-knockout mice develop autoimmunity with lymphocyte accumulation revealed both a bHLH-factor competition mechanism and an essential in vivo role in immune homeostasis.","evidence":"Yeast two-hybrid, co-immunoprecipitation, and reporter assays for USF interaction; Stra13-KO mouse model with lymphocyte phenotyping","pmids":["11498797","11668339"],"confidence":"High","gaps":["Direct transcriptional targets in T cells unknown","Whether immune phenotype reflects repressor or activator function unclear","Redundancy with BHLHE41 not addressed"]},{"year":2002,"claim":"Identification of HIF-1α/β binding to the BHLHE40 promoter HRE placed BHLHE40 as a direct hypoxia-responsive gene, establishing its role as a transcriptional effector linking oxygen sensing to downstream gene regulation.","evidence":"Luciferase reporters, EMSA with HIF-1α/β, deletion/mutation analysis of HRE","pmids":["12354771"],"confidence":"High","gaps":["Hypoxia-regulated target genes of BHLHE40 not yet catalogued","Relationship between hypoxia and circadian functions not integrated"]},{"year":2003,"claim":"Showing that CLOCK:BMAL1 drives circadian BHLHE40 expression and that BHLHE40 represses its own promoter via E-box binding established BHLHE40 as an autoregulatory component of the peripheral circadian clock.","evidence":"Reporter assays and microarray in Stra13−/− mouse liver; DEC1-DEC2 cross-repression via E-box mutagenesis","pmids":["14581485","12624110"],"confidence":"High","gaps":["Whether BHLHE40 is essential for core clock function or only modulatory","Redundancy with DEC2/CRY in clock repression not resolved"]},{"year":2004,"claim":"Dissecting that BHLHE40 represses mPer1 through direct E-box DNA binding rather than through protein-protein interaction with BMAL1 resolved the primary repression mechanism in the clock circuit, while identification of STAT3 interaction revealed a non-E-box co-regulatory mode.","evidence":"DNA-binding mutant analysis for mPer1 repression; yeast two-hybrid and co-IP for STAT3 interaction with functional reporter assays","pmids":["15193144","15223310"],"confidence":"High","gaps":["Genome-wide binding profile not available","STAT3 interaction not validated in vivo","Whether E-box-dependent and STAT3-dependent functions operate in the same cell types unclear"]},{"year":2006,"claim":"Demonstrating that BHLHE40 recruits HDAC1 via its C-terminal domain to repress STAT1 and that it activates the survivin promoter through Sp1 sites established HDAC-dependent repression and context-dependent activation as dual modes of action.","evidence":"ChIP, TSA inhibition, Sp1-site mutagenesis, and EMSA at survivin and STAT1 promoters","pmids":["16878149","16462771"],"confidence":"High","gaps":["Full HDAC family involvement not mapped","Structural basis for context-dependent activation vs. repression unknown"]},{"year":2007,"claim":"Discovery that BHLHE40 stabilizes p53 by blocking Mdm2-mediated ubiquitination and that p53 reciprocally induces BHLHE40 transcription defined a positive-feedback circuit coupling DNA damage to apoptosis and senescence; separately, BHLHE40 was shown to antagonize Notch signaling in satellite cells and to promote TGF-β-dependent metastatic survival.","evidence":"Stra13−/− thymocytes with reduced p53/Puma/Noxa after irradiation; in vitro ubiquitination assays; Notch rescue in KO myoblasts; dominant-negative DEC1 in metastasis model","pmids":["18025081","17347673","17502421","17942899"],"confidence":"High","gaps":["Direct p53-binding domain on BHLHE40 not mapped","Whether Notch antagonism is direct or transcriptional unclear","TGF-β survival mechanism not fully defined"]},{"year":2008,"claim":"A series of studies identified endogenous BHLHE40 target promoters (BDNF exon 4, MLH1, SREBP-1c, ChREBP targets, ATP1B1) repressed through E-box binding and HDAC-dependent mechanisms, and showed TGF-β/SMAD3-dependent induction of BHLHE40 mediates non-photic circadian clock resetting in vivo.","evidence":"EMSA/ChIP in hippocampal neurons and hepatocytes; Bhlhe40−/− mice for BDNF and clock resetting; TSA rescue for MLH1; Dec1−/− mice with TGF-β injection","pmids":["18234890","18345027","18838394","18602890","19029909"],"confidence":"High","gaps":["Genome-wide target repertoire still lacking","Tissue-specific vs. universal targets not distinguished"]},{"year":2011,"claim":"Identification of SUMOylation at K159/K279 as a stabilizing modification that promotes nuclear retention, HDAC1 recruitment, and enhanced CLOCK:BMAL1 repression provided the first post-translational regulatory code for BHLHE40 activity.","evidence":"SUMO modification assays, site-directed mutagenesis, ubiquitination assays, reporter assays in COS-7/MCF-7 cells","pmids":["21829689","22905217"],"confidence":"High","gaps":["SUMO E3 ligase responsible not identified","In vivo relevance of SUMOylation not tested","Interplay between SUMOylation and ubiquitination pathways not resolved"]},{"year":2014,"claim":"Defining BHLHE40 as a cell-intrinsic regulator of GM-CSF and IL-10 in T cells, identifying the SCFβTrCP/CK1-dependent degradation and USP17-dependent stabilization axis, and showing BHLHE40 co-activates IFN-γ with T-bet at the Ifng locus established its immune effector function and protein turnover control.","evidence":"Bhlhe40−/− EAE model with IL-10R blockade rescue; Co-IP of SCFβTrCP and USP17 with ubiquitination assays; ChIP at Ifng locus with histone acetylation analysis","pmids":["24699451","25202122","27226296"],"confidence":"High","gaps":["Whether T-bet-dependent and -independent IFN-γ regulation co-occur in same T cell subsets","CK1 phosphorylation sites on BHLHE40 not fully mapped","USP17 regulation in immune cells unknown"]},{"year":2015,"claim":"Showing that BHLHE40 directly binds and represses PGC-1α transactivation by recruiting HDACs and preventing relief of PGC-1α intramolecular repression established BHLHE40 as a metabolic corepressor controlling mitochondrial gene programs.","evidence":"Co-immunoprecipitation of Bhlhe40-PGC-1α, ChIP at target promoters, HDAC recruitment assays, siRNA knockdown","pmids":["25963661"],"confidence":"High","gaps":["In vivo metabolic phenotype of Bhlhe40 KO not fully characterized","Peroxisome vs. mitochondria specificity mechanism unclear"]},{"year":2019,"claim":"Genome-wide binding studies and functional genetics revealed BHLHE40 sustains mitochondrial fitness and epigenetic openness in tissue-resident memory and tumor-infiltrating CD8+ T cells, controls macrophage self-renewal by repressing Maf family genes, and maintains alveolar macrophage identity—establishing BHLHE40 as a master regulator of immune cell fitness and identity.","evidence":"ChIP-seq in peritoneal and alveolar macrophages; ATAC-seq in TILs; conditional KO with anti-PD-L1 treatment; Bhlhe40/41 double-KO","pmids":["31533057","31061528","31414712"],"confidence":"High","gaps":["Direct transcriptional targets mediating mitochondrial fitness in T cells not defined","Whether macrophage and T cell programs share common BHLHE40 target genes","BHLHE40 vs. BHLHE41 functional redundancy quantitatively unresolved"]},{"year":2022,"claim":"CRISPR screens and in vivo models placed BHLHE40 at the differentiation checkpoint between progenitor and intermediate exhausted CD8+ T cells and showed it is required for effective anti-PD-1/anti-CTLA-4 immunotherapy responses, linking its transcriptional program to clinical checkpoint blockade efficacy.","evidence":"Genome-wide CRISPR screen with chronic stimulation model; Bhlhe40−/− tumor models with ICT; scRNA-seq","pmids":["37595022","35181783"],"confidence":"Medium","gaps":["Direct gene targets at the exhaustion checkpoint not mapped by ChIP","Human patient validation limited","Whether BHLHE40 is therapeutically targetable"]},{"year":2023,"claim":"Multi-omics approaches revealed that BHLHE40 physically mediates enhancer-promoter looping at the SREBF1 locus to regulate lipid desaturation and ferroptosis resistance, and represses MAFA via displacement of PDX1 to suppress insulin secretion in hypoxic β-cells, expanding its mechanistic repertoire to 3D genome organization and metabolic disease.","evidence":"ChIP-seq, Hi-C/chromosome conformation capture at SREBF1; ChIP at Mafa enhancer in MIN6 cells and ob/ob mice with rescue","pmids":["38064101","37341148"],"confidence":"High","gaps":["Genome-wide enhancer-promoter bridging role not assessed beyond SREBF1","Structural basis for chromatin looping activity unknown","β-cell findings not validated in human islets"]},{"year":2024,"claim":"Demonstrating that BHLHE40/41 loss in macrophages de-represses disease-associated macrophage (DLAM) genes governing cholesterol efflux and lysosomal processing established BHLHE40 as a gatekeeper of macrophage activation states relevant to neurodegeneration and atherosclerosis.","evidence":"BHLHE40/41 KO in iPSC-derived microglia, THP-1, and mouse models; scRNA-seq gene regulatory network reconstruction; lipid/lysosomal functional assays","pmids":["38448474"],"confidence":"High","gaps":["In vivo disease model validation (e.g., atherosclerosis, Alzheimer's) not performed","Whether therapeutic de-repression of DLAM is beneficial or detrimental long-term"]},{"year":null,"claim":"Despite extensive characterization, the structural basis for BHLHE40's dual repressor/activator activity, its genome-wide binding landscape across immune cell states, the full extent of BHLHE40-BHLHE41 functional redundancy, and whether BHLHE40 can be therapeutically modulated in cancer immunotherapy or metabolic disease remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of BHLHE40 or its complexes","Systematic comparison of BHLHE40 vs. BHLHE41 ChIP-seq across cell types lacking","No pharmacological tool compounds reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,7,16,18,19,20,21,23,34,35,50]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,5,6,10,11,25,26,27,33,42,43,50]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[31]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[13,33,45]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,25,44]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,5,6,10,11,25,26,27,33,42,43,50]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[6,7,17,40]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,28,36,37,41,42,46,47,49,51,53]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3,10,18,34,52]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[25,26,31]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[12,23,26,42]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[13]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[18,20,50,53]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,14,15,44,45]}],"complexes":[],"partners":["HDAC1","HDAC2","STAT3","USF1","PGC1A","RUNX1","TBX21","TP53"],"other_free_text":[]},"mechanistic_narrative":"BHLHE40 is a basic helix-loop-helix transcriptional repressor—and context-dependent activator—that integrates circadian, hypoxic, and immune signals to control gene expression programs governing cell proliferation, differentiation, and inflammatory responses. It represses target genes primarily by competing with CLOCK:BMAL1 and other bHLH/bHLHZip factors (USF, ChREBP, SREBP-1c, SP1) for E-box binding and by recruiting HDAC1/2 to promoters, with SUMOylation at K159/K279 stabilizing the protein and potentiating HDAC1-dependent repression [PMID:9284045, PMID:21829689, PMID:22905217, PMID:14581485, PMID:18838394]. In immune cells, BHLHE40 is required cell-intrinsically for GM-CSF and IFN-γ production, IL-10 suppression, macrophage self-renewal, germinal center restraint, and CD8+ T cell exhaustion checkpoint control; its loss renders T cells nonencephalitogenic and impairs anti-tumor immunity and checkpoint-blockade responses [PMID:24699451, PMID:29773643, PMID:31061528, PMID:31533057, PMID:37595022]. BHLHE40 protein stability is governed by SCFβTrCP/CK1-mediated ubiquitination driving degradation and USP17-mediated deubiquitination stabilizing it after DNA damage, while interactions with p53, STAT3, T-bet, Runx1, and PGC-1α direct its activity toward specific gene programs including apoptosis, cytokine regulation, and mitochondrial/metabolic control [PMID:25202122, PMID:17347673, PMID:15223310, PMID:27226296, PMID:25963661]."},"prefetch_data":{"uniprot":{"accession":"O14503","full_name":"Class E basic helix-loop-helix protein 40","aliases":["Class B basic helix-loop-helix protein 2","bHLHb2","Differentially expressed in chondrocytes protein 1","DEC1","Enhancer-of-split and hairy-related protein 2","SHARP-2","Stimulated by retinoic acid gene 13 protein"],"length_aa":412,"mass_kda":45.5,"function":"Transcriptional repressor involved in the regulation of the circadian rhythm by negatively regulating the activity of the clock genes and clock-controlled genes (PubMed:12397359, PubMed:18411297). Acts as the negative limb of a novel autoregulatory feedback loop (DEC loop) which differs from the one formed by the PER and CRY transcriptional repressors (PER/CRY loop) (PubMed:14672706). Both these loops are interlocked as it represses the expression of PER1/2 and in turn is repressed by PER1/2 and CRY1/2 (PubMed:15193144). Represses the activity of the circadian transcriptional activator: CLOCK-BMAL1|BMAL2 heterodimer by competing for the binding to E-box elements (5'-CACGTG-3') found within the promoters of its target genes (PubMed:15560782). Negatively regulates its own expression and the expression of DBP and BHLHE41/DEC2 (PubMed:14672706). Acts as a corepressor of RXR and the RXR-LXR heterodimers and represses the ligand-induced RXRA and NR1H3/LXRA transactivation activity (PubMed:19786558). May be involved in the regulation of chondrocyte differentiation via the cAMP pathway (PubMed:19786558). Represses the transcription of NR0B2 and attentuates the transactivation of NR0B2 by the CLOCK-BMAL1 complex (PubMed:28797635). Drives the circadian rhythm of blood pressure through transcriptional repression of ATP1B1 in the cardiovascular system (PubMed:30012868)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/O14503/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BHLHE40","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BHLHE40","total_profiled":1310},"omim":[{"mim_id":"615128","title":"CENTROMERIC PROTEIN X; CENPX","url":"https://www.omim.org/entry/615128"},{"mim_id":"606200","title":"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E41; BHLHE41","url":"https://www.omim.org/entry/606200"},{"mim_id":"604256","title":"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E40; BHLHE40","url":"https://www.omim.org/entry/604256"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear bodies","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BHLHE40"},"hgnc":{"alias_symbol":["DEC1","SHARP2","Clast5"],"prev_symbol":["STRA13","BHLHB2"]},"alphafold":{"accession":"O14503","domains":[{"cath_id":"4.10.280.10","chopping":"52-128","consensus_level":"high","plddt":89.719,"start":52,"end":128},{"cath_id":"-","chopping":"133-184","consensus_level":"high","plddt":81.8183,"start":133,"end":184}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14503","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14503-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14503-F1-predicted_aligned_error_v6.png","plddt_mean":59.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BHLHE40","jax_strain_url":"https://www.jax.org/strain/search?query=BHLHE40"},"sequence":{"accession":"O14503","fasta_url":"https://rest.uniprot.org/uniprotkb/O14503.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14503/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14503"}},"corpus_meta":[{"pmid":"35688610","id":"PMC_35688610","title":"Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.","date":"2022","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/35688610","citation_count":238,"is_preprint":false},{"pmid":"9284045","id":"PMC_9284045","title":"Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9284045","citation_count":223,"is_preprint":false},{"pmid":"31533057","id":"PMC_31533057","title":"The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8+ T Cell Fitness and Functionality.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31533057","citation_count":196,"is_preprint":false},{"pmid":"12354771","id":"PMC_12354771","title":"Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12354771","citation_count":194,"is_preprint":false},{"pmid":"11668339","id":"PMC_11668339","title":"Defective T cell activation and autoimmune disorder in Stra13-deficient mice.","date":"2001","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11668339","citation_count":151,"is_preprint":false},{"pmid":"24699451","id":"PMC_24699451","title":"Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24699451","citation_count":149,"is_preprint":false},{"pmid":"15196947","id":"PMC_15196947","title":"The Hand1, Stra13 and Gcm1 transcription factors override FGF signaling to promote terminal differentiation of trophoblast stem cells.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15196947","citation_count":123,"is_preprint":false},{"pmid":"29773643","id":"PMC_29773643","title":"The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination.","date":"2018","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29773643","citation_count":113,"is_preprint":false},{"pmid":"19029909","id":"PMC_19029909","title":"Activation of TGF-beta/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts.","date":"2008","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19029909","citation_count":110,"is_preprint":false},{"pmid":"18025081","id":"PMC_18025081","title":"DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18025081","citation_count":108,"is_preprint":false},{"pmid":"16462771","id":"PMC_16462771","title":"The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16462771","citation_count":103,"is_preprint":false},{"pmid":"12624110","id":"PMC_12624110","title":"DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12624110","citation_count":102,"is_preprint":false},{"pmid":"12384505","id":"PMC_12384505","title":"Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12384505","citation_count":98,"is_preprint":false},{"pmid":"25248482","id":"PMC_25248482","title":"DEC1/STRA13/SHARP2 and DEC2/SHARP1 coordinate physiological processes, including circadian rhythms in response to environmental stimuli.","date":"2014","source":"Current topics in developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25248482","citation_count":89,"is_preprint":false},{"pmid":"23878307","id":"PMC_23878307","title":"CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23878307","citation_count":89,"is_preprint":false},{"pmid":"26819638","id":"PMC_26819638","title":"DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression.","date":"2016","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26819638","citation_count":86,"is_preprint":false},{"pmid":"26834156","id":"PMC_26834156","title":"IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.","date":"2016","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26834156","citation_count":84,"is_preprint":false},{"pmid":"17942899","id":"PMC_17942899","title":"Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17942899","citation_count":83,"is_preprint":false},{"pmid":"18234890","id":"PMC_18234890","title":"BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18234890","citation_count":82,"is_preprint":false},{"pmid":"18345027","id":"PMC_18345027","title":"Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18345027","citation_count":80,"is_preprint":false},{"pmid":"31414712","id":"PMC_31414712","title":"Bhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self-renewal and identity.","date":"2019","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/31414712","citation_count":78,"is_preprint":false},{"pmid":"14581485","id":"PMC_14581485","title":"The transcriptional repressor STRA13 regulates a subset of peripheral circadian outputs.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14581485","citation_count":72,"is_preprint":false},{"pmid":"22825629","id":"PMC_22825629","title":"The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22825629","citation_count":71,"is_preprint":false},{"pmid":"31061528","id":"PMC_31061528","title":"Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31061528","citation_count":67,"is_preprint":false},{"pmid":"37595022","id":"PMC_37595022","title":"In vitro modeling of CD8+ T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37595022","citation_count":66,"is_preprint":false},{"pmid":"16878149","id":"PMC_16878149","title":"Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16878149","citation_count":66,"is_preprint":false},{"pmid":"17502421","id":"PMC_17502421","title":"Stra13 regulates satellite cell activation by antagonizing Notch signaling.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17502421","citation_count":65,"is_preprint":false},{"pmid":"23578198","id":"PMC_23578198","title":"Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells.","date":"2013","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/23578198","citation_count":61,"is_preprint":false},{"pmid":"15066123","id":"PMC_15066123","title":"Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBP.","date":"2004","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15066123","citation_count":58,"is_preprint":false},{"pmid":"18838394","id":"PMC_18838394","title":"Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18838394","citation_count":56,"is_preprint":false},{"pmid":"15223310","id":"PMC_15223310","title":"STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15223310","citation_count":55,"is_preprint":false},{"pmid":"21506129","id":"PMC_21506129","title":"Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1.","date":"2011","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21506129","citation_count":53,"is_preprint":false},{"pmid":"30285805","id":"PMC_30285805","title":"BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.","date":"2018","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/30285805","citation_count":51,"is_preprint":false},{"pmid":"18602890","id":"PMC_18602890","title":"Regulation of lipogenesis via BHLHB2/DEC1 and ChREBP feedback looping.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18602890","citation_count":50,"is_preprint":false},{"pmid":"16672257","id":"PMC_16672257","title":"SHARP2: protein-protein interaction predictions using patch analysis.","date":"2006","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16672257","citation_count":48,"is_preprint":false},{"pmid":"21057086","id":"PMC_21057086","title":"The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21057086","citation_count":48,"is_preprint":false},{"pmid":"21327324","id":"PMC_21327324","title":"Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells.","date":"2011","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21327324","citation_count":46,"is_preprint":false},{"pmid":"10612805","id":"PMC_10612805","title":"Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32.","date":"2000","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10612805","citation_count":46,"is_preprint":false},{"pmid":"33176151","id":"PMC_33176151","title":"TFEB Transcriptional Responses Reveal Negative Feedback by BHLHE40 and BHLHE41.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33176151","citation_count":45,"is_preprint":false},{"pmid":"22678901","id":"PMC_22678901","title":"Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13.","date":"2012","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22678901","citation_count":44,"is_preprint":false},{"pmid":"26391953","id":"PMC_26391953","title":"Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26391953","citation_count":42,"is_preprint":false},{"pmid":"26468276","id":"PMC_26468276","title":"Hypoxia Inhibits Myogenic Differentiation through p53 Protein-dependent Induction of Bhlhe40 Protein.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26468276","citation_count":41,"is_preprint":false},{"pmid":"27226296","id":"PMC_27226296","title":"Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27226296","citation_count":41,"is_preprint":false},{"pmid":"15193144","id":"PMC_15193144","title":"DNA binding, but not interaction with Bmal1, is responsible for DEC1-mediated transcription regulation of the circadian gene mPer1.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15193144","citation_count":40,"is_preprint":false},{"pmid":"16267380","id":"PMC_16267380","title":"Tissue-specific disruption of rhythmic expression of Dec1 and Dec2 in clock mutant mice.","date":"2005","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/16267380","citation_count":40,"is_preprint":false},{"pmid":"11432722","id":"PMC_11432722","title":"Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway.","date":"2001","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11432722","citation_count":39,"is_preprint":false},{"pmid":"38657117","id":"PMC_38657117","title":"Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38657117","citation_count":38,"is_preprint":false},{"pmid":"38448474","id":"PMC_38448474","title":"BHLHE40/41 regulate microglia and peripheral macrophage responses associated with Alzheimer's disease and other disorders of lipid-rich tissues.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38448474","citation_count":38,"is_preprint":false},{"pmid":"32577154","id":"PMC_32577154","title":"Non-circadian aspects of BHLHE40 cellular function in cancer.","date":"2020","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32577154","citation_count":38,"is_preprint":false},{"pmid":"17347673","id":"PMC_17347673","title":"Stra13 is induced by genotoxic stress and regulates ionizing-radiation-induced apoptosis.","date":"2007","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/17347673","citation_count":38,"is_preprint":false},{"pmid":"35181783","id":"PMC_35181783","title":"BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy.","date":"2022","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/35181783","citation_count":37,"is_preprint":false},{"pmid":"21829689","id":"PMC_21829689","title":"SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21829689","citation_count":37,"is_preprint":false},{"pmid":"15580306","id":"PMC_15580306","title":"Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15580306","citation_count":37,"is_preprint":false},{"pmid":"30158530","id":"PMC_30158530","title":"The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30158530","citation_count":36,"is_preprint":false},{"pmid":"15719173","id":"PMC_15719173","title":"Association, mutual stabilization, and transcriptional activity of the STRA13 and MSP58 proteins.","date":"2005","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/15719173","citation_count":34,"is_preprint":false},{"pmid":"25248481","id":"PMC_25248481","title":"Stra13 and Sharp-1, the non-grouchy regulators of development and disease.","date":"2014","source":"Current topics in developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25248481","citation_count":33,"is_preprint":false},{"pmid":"30012868","id":"PMC_30012868","title":"Dec1 and CLOCK Regulate Na+/K+-ATPase β1 Subunit Expression and Blood Pressure.","date":"2018","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/30012868","citation_count":33,"is_preprint":false},{"pmid":"24404147","id":"PMC_24404147","title":"DEC1 coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73 expression.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24404147","citation_count":32,"is_preprint":false},{"pmid":"11890681","id":"PMC_11890681","title":"Clast5/Stra13 is a negative regulator of B lymphocyte activation.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11890681","citation_count":32,"is_preprint":false},{"pmid":"34919144","id":"PMC_34919144","title":"Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis.","date":"2021","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34919144","citation_count":31,"is_preprint":false},{"pmid":"29204860","id":"PMC_29204860","title":"DEC1 is required for anti-apoptotic activity of gastric cancer cells under hypoxia by promoting Survivin expression.","date":"2017","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/29204860","citation_count":31,"is_preprint":false},{"pmid":"22610404","id":"PMC_22610404","title":"Differentiated embryo chondrocyte 1 (DEC1) represses PPARγ2 gene through interacting with CCAAT/enhancer binding protein β (C/EBPβ).","date":"2012","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/22610404","citation_count":31,"is_preprint":false},{"pmid":"25202122","id":"PMC_25202122","title":"USP17- and SCFβTrCP--regulated degradation of DEC1 controls the DNA damage response.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25202122","citation_count":30,"is_preprint":false},{"pmid":"33296081","id":"PMC_33296081","title":"Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ.","date":"2021","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33296081","citation_count":30,"is_preprint":false},{"pmid":"21317427","id":"PMC_21317427","title":"DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21317427","citation_count":30,"is_preprint":false},{"pmid":"31900338","id":"PMC_31900338","title":"BHLHE40 Promotes TH2 Cell-Mediated Antihelminth Immunity and Reveals Cooperative CSF2RB Family Cytokines.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31900338","citation_count":29,"is_preprint":false},{"pmid":"25340473","id":"PMC_25340473","title":"Mice lacking the circadian modulators SHARP1 and SHARP2 display altered sleep and mixed state endophenotypes of psychiatric disorders.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25340473","citation_count":29,"is_preprint":false},{"pmid":"15114665","id":"PMC_15114665","title":"Impaired lymphocyte development and function in Clast5/Stra13/DEC1-transgenic mice.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15114665","citation_count":29,"is_preprint":false},{"pmid":"38064101","id":"PMC_38064101","title":"BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38064101","citation_count":28,"is_preprint":false},{"pmid":"19032342","id":"PMC_19032342","title":"Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression.","date":"2008","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19032342","citation_count":28,"is_preprint":false},{"pmid":"12594185","id":"PMC_12594185","title":"Stra13, a prostaglandin E2-induced gene, regulates the cellular redox state of podocytes.","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12594185","citation_count":27,"is_preprint":false},{"pmid":"35355710","id":"PMC_35355710","title":"Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35355710","citation_count":27,"is_preprint":false},{"pmid":"32483833","id":"PMC_32483833","title":"LncRNA-ES3 inhibition by Bhlhe40 is involved in high glucose-induced calcification/senescence of vascular smooth muscle cells.","date":"2020","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32483833","citation_count":27,"is_preprint":false},{"pmid":"15038852","id":"PMC_15038852","title":"Dec1 and Dec2 expression is disrupted in the suprachiasmatic nuclei of Clock mutant mice.","date":"2004","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/15038852","citation_count":26,"is_preprint":false},{"pmid":"31907974","id":"PMC_31907974","title":"Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling.","date":"2020","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31907974","citation_count":26,"is_preprint":false},{"pmid":"26498531","id":"PMC_26498531","title":"DEC1 negatively regulates AMPK activity via LKB1.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26498531","citation_count":26,"is_preprint":false},{"pmid":"30391825","id":"PMC_30391825","title":"Bhlhe40 differentially regulates the function and number of peroxisomes and mitochondria in myogenic cells.","date":"2018","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/30391825","citation_count":24,"is_preprint":false},{"pmid":"37341148","id":"PMC_37341148","title":"Hypoxia causes pancreatic β-cell dysfunction and impairs insulin secretion by activating the transcriptional repressor BHLHE40.","date":"2023","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/37341148","citation_count":24,"is_preprint":false},{"pmid":"22244086","id":"PMC_22244086","title":"Regulation of basic helix-loop-helix transcription factors Dec1 and Dec2 by RORα and their roles in adipogenesis.","date":"2012","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/22244086","citation_count":24,"is_preprint":false},{"pmid":"38172306","id":"PMC_38172306","title":"Empagliflozin ameliorates vascular calcification in diabetic mice through inhibiting Bhlhe40-dependent NLRP3 inflammasome activation.","date":"2024","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/38172306","citation_count":23,"is_preprint":false},{"pmid":"22905217","id":"PMC_22905217","title":"SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22905217","citation_count":23,"is_preprint":false},{"pmid":"11498797","id":"PMC_11498797","title":"Cross-regulatory interaction between Stra13 and USF results in functional antagonism.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11498797","citation_count":22,"is_preprint":false},{"pmid":"30002194","id":"PMC_30002194","title":"Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.","date":"2018","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/30002194","citation_count":20,"is_preprint":false},{"pmid":"19522704","id":"PMC_19522704","title":"P/CAF rescues the Bhlhe40-mediated repression of MyoD transactivation.","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19522704","citation_count":20,"is_preprint":false},{"pmid":"36484960","id":"PMC_36484960","title":"Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension.","date":"2022","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/36484960","citation_count":20,"is_preprint":false},{"pmid":"24100543","id":"PMC_24100543","title":"Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma.","date":"2013","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24100543","citation_count":20,"is_preprint":false},{"pmid":"34305917","id":"PMC_34305917","title":"BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34305917","citation_count":20,"is_preprint":false},{"pmid":"32896382","id":"PMC_32896382","title":"Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32896382","citation_count":19,"is_preprint":false},{"pmid":"25963661","id":"PMC_25963661","title":"Bhlhe40 Represses PGC-1α Activity on Metabolic Gene Promoters in Myogenic Cells.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25963661","citation_count":19,"is_preprint":false},{"pmid":"28734031","id":"PMC_28734031","title":"Downregulation of DEC1 contributes to the neurotoxicity induced by MPP+ by suppressing PI3K/Akt/GSK3β pathway.","date":"2017","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28734031","citation_count":18,"is_preprint":false},{"pmid":"29715265","id":"PMC_29715265","title":"Mice lacking the transcriptional regulator Bhlhe40 have enhanced neuronal excitability and impaired synaptic plasticity in the hippocampus.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29715265","citation_count":18,"is_preprint":false},{"pmid":"31914631","id":"PMC_31914631","title":"Upexpression of BHLHE40 in gastric epithelial cells increases CXCL12 production through interaction with p-STAT3 in Helicobacter pylori-associated gastritis.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31914631","citation_count":17,"is_preprint":false},{"pmid":"29882288","id":"PMC_29882288","title":"Transcription factor DEC1 is required for maximal experimentally induced periodontal inflammation.","date":"2018","source":"Journal of periodontal research","url":"https://pubmed.ncbi.nlm.nih.gov/29882288","citation_count":17,"is_preprint":false},{"pmid":"35689549","id":"PMC_35689549","title":"Upregulation of INHBA mediated by the transcription factor BHLHE40 promotes colon cancer cell proliferation and migration.","date":"2022","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/35689549","citation_count":16,"is_preprint":false},{"pmid":"25876658","id":"PMC_25876658","title":"Basic helix-loop-helix transcription factor DEC1 regulates the cisplatin-induced apoptotic pathway of human esophageal cancer cells.","date":"2015","source":"Biomedical research (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/25876658","citation_count":16,"is_preprint":false},{"pmid":"36890812","id":"PMC_36890812","title":"Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of ADAM19 and KLF7.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36890812","citation_count":16,"is_preprint":false},{"pmid":"32360904","id":"PMC_32360904","title":"Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1.","date":"2020","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32360904","citation_count":16,"is_preprint":false},{"pmid":"35122398","id":"PMC_35122398","title":"DEC1 promotes progression of Helicobacter pylori-positive gastric cancer by regulating Akt/NF-κB pathway.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35122398","citation_count":15,"is_preprint":false},{"pmid":"17097613","id":"PMC_17097613","title":"Molecular analysis of Dec1 and Dec2 in the peripheral circadian clock of zebrafish photosensitive cells.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17097613","citation_count":15,"is_preprint":false},{"pmid":"36194366","id":"PMC_36194366","title":"Long noncoding RNA SNHG1 alleviates high glucose-induced vascular smooth muscle cells calcification/senescence by post-transcriptionally regulating Bhlhe40 and autophagy via Atg10.","date":"2022","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36194366","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49588,"output_tokens":11699,"usd":0.162125},"stage2":{"model":"claude-opus-4-6","input_tokens":15988,"output_tokens":4604,"usd":0.29256},"total_usd":0.454685,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"BHLHE40 (Stra13) encodes a bHLH protein that represses activated transcription through an alpha-helix rich C-terminal domain, in part by interaction with general factors of the basal transcription machinery, and does not bind the canonical E-box or N-box motifs recognized by other bHLH proteins.\",\n      \"method\": \"Transient transfection reporter assays, protein-protein interaction studies, overexpression in P19 cells\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original cloning paper with functional domain characterization and multiple orthogonal assays; foundational study\",\n      \"pmids\": [\"9284045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Stra13 (BHLHE40) interacts physically with the bHLHZip protein USF through its C-terminal repression domain and the DNA-binding domain of USF; co-expression causes mutual functional antagonism, with USF abrogating Stra13-mediated repression and Stra13 inhibiting USF DNA binding and transactivation.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, reporter assays, EMSA\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction confirmed by multiple methods including Y2H and functional co-expression assays\",\n      \"pmids\": [\"11498797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"BHLHE40 (Stra13) is required for proper CD4+ T cell activation and elimination of activated lymphocytes; Stra13-deficient mice develop autoimmune disease with accumulation of activated T and B cells, indicating a key role in lymphocyte homeostasis.\",\n      \"method\": \"Stra13-knockout mouse model, in vivo lymphocyte phenotyping, immunology assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype; highly cited foundational study\",\n      \"pmids\": [\"11668339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HIF-1α and HIF-1β directly bind functional hypoxia response elements (HREs) in the BHLHE40 (DEC1) promoter region (-524 to -401), activating its transcription in response to hypoxia or CoCl2.\",\n      \"method\": \"Luciferase reporter assays, EMSA showing HIF-1α/β binding to HRE, deletion/mutation analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct HIF-1 binding to promoter demonstrated by EMSA and mutational dissection\",\n      \"pmids\": [\"12354771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DEC1 (BHLHE40) promotes chondrocyte differentiation when overexpressed in ATDC5 cells, antagonizes the inhibitory action of PTH/PTHrP, and induces expression of type II collagen, Indian hedgehog, and Runx2.\",\n      \"method\": \"Forced expression in ATDC5 cells and bone marrow mesenchymal stem cells, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with defined molecular targets but single-lab study\",\n      \"pmids\": [\"12384505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DEC1 (BHLHE40) directly binds an E-box motif in the proximal promoter of DEC2 and represses DEC2 transcription; DNA-binding-defective DEC1 mutants lose this repressive activity.\",\n      \"method\": \"Reporter assays with deletion/site-directed mutants, stable transfectants with tetracycline-inducible DEC1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct DNA binding shown with mutational validation and functional consequence\",\n      \"pmids\": [\"12624110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BHLHE40 (Stra13) circadian expression in peripheral tissues is driven by the CLOCK-BMAL1 heterodimer via a response element in the proximal promoter; Stra13 in turn represses its own CLOCK-BMAL1-driven transcription (autorepression), and CRY1 strongly represses CLOCK-BMAL1-dependent Stra13 activation.\",\n      \"method\": \"Reporter assays, microarray gene expression in Stra13-/- mice liver, genetic knockout\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including genetic KO and functional promoter analysis\",\n      \"pmids\": [\"14581485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DEC1 (BHLHE40) represses the mPer1 promoter through direct E-box binding rather than through protein-protein interaction with Bmal1; DNA-binding mutants of DEC1 that retain Bmal1 interaction cannot repress the mPer1 promoter.\",\n      \"method\": \"Reporter assays, yeast two-hybrid, EMSA, mutational analysis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct mechanistic dissection of DNA binding vs. protein interaction using mutants\",\n      \"pmids\": [\"15193144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"STRA13 (BHLHE40) interacts with phosphorylated (active) STAT3α and STAT3β via its HLH and C-terminal regions; STRA13 can activate transcription from STAT-dependent elements and modulates the transcriptional outcome of STAT3 on the Fas promoter.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, luciferase reporter assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction identified by Y2H and confirmed by Co-IP with functional reporter assays\",\n      \"pmids\": [\"15223310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"STRA13 (BHLHE40) interacts with MSP58 via its basic domain (with MSP58's FHA domain required), and complex formation protects both proteins from proteasome-mediated degradation; together they synergistically co-operate in STRA13 promoter-driven transcription repression.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, phospho-peptide mapping, protein half-life assays, reporter assays\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods but single lab\",\n      \"pmids\": [\"15719173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"STRA13 (BHLHE40) represses STAT1 transcription through a mechanism requiring its C-terminal trans-activation domain which binds HDAC1; this HDAC-dependent mechanism also results in repression of STAT1 target genes (MHC antigen-presenting genes, CASP1) under hypoxia via VHL/HIF-1 activation.\",\n      \"method\": \"Luciferase reporter assays with deletion/site-directed mutants, ChIP, TSA inhibition\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including ChIP and TSA validation of HDAC mechanism\",\n      \"pmids\": [\"16878149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DEC1 (BHLHE40) transactivates the survivin promoter through two Sp1 sites, and DEC1 protein is detected at the survivin promoter by EMSA and ChIP, establishing survivin as a direct transcriptional target.\",\n      \"method\": \"Reporter assays with Sp1 site mutants, EMSA, ChIP\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding demonstrated by EMSA and ChIP with mutational validation\",\n      \"pmids\": [\"16462771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DEC1 (BHLHE40) is a direct transcriptional target of the p53 family; p53 family proteins bind and activate the DEC1 promoter, and DEC1 overexpression induces G1 arrest and premature senescence independently of p21.\",\n      \"method\": \"cDNA microarray, luciferase reporter assays, ChIP showing p53 binding to DEC1 promoter, siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct p53 binding to DEC1 promoter shown by ChIP, with functional senescence phenotype\",\n      \"pmids\": [\"18025081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Stra13 (BHLHE40) physically interacts with p53 in vitro and prevents Mdm2-mediated ubiquitination and nuclear export of p53, thereby stabilizing p53 levels to promote ionizing-radiation-induced apoptosis; Stra13-deficient thymocytes show reduced p53, Puma, and Noxa expression after irradiation.\",\n      \"method\": \"Stra13-/- mouse model, in vitro interaction assay, ubiquitination assay, gene expression\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of interaction with functional validation in KO cells\",\n      \"pmids\": [\"17347673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Stra13 (BHLHE40) modulates satellite cell activation by antagonizing Notch signaling; Stra13-/- primary myoblasts show enhanced Notch activity, increased proliferation, and defective differentiation, and inhibition of Notch signaling rescues the regeneration defect of Stra13-/- mice.\",\n      \"method\": \"Stra13 knockout mouse model, in vitro Notch pathway reporter assays, pharmacological Notch inhibition rescue\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis established by genetic KO and pharmacological rescue\",\n      \"pmids\": [\"17502421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DEC1 (BHLHE40) is induced by TGF-β signaling in mammary carcinoma cells and promotes cell survival; knockdown of DEC1 abrogates TGF-β-promoted cell survival, and a dominant-negative DEC1 mutant prevents lung and liver metastasis in vivo.\",\n      \"method\": \"Microarray, kinase inhibitor treatment, dominant-negative overexpression, in vivo metastasis model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro evidence with multiple mechanistic interventions\",\n      \"pmids\": [\"17942899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BHLHE40 (BHLHB2) binds a specific sequence within Bdnf promoter 4 and mediates transcriptional repression; NMDA receptor activation reduces BHLHB2 occupancy at promoter 4, correlating with de-repressed BDNF exon 4 expression; Bhlhb2-/- mice show increased hippocampal BDNF exon 4 mRNA.\",\n      \"method\": \"EMSA, ChIP in hippocampal neurons, Bhlhb2 knockout mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct DNA binding by EMSA and ChIP confirmed in vivo by KO phenotype\",\n      \"pmids\": [\"18234890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TGF-β/activin signaling resets the circadian clock through SMAD3-dependent immediate-early induction of Dec1 (BHLHE40); intraperitoneal TGF-β injection in wild-type but not Dec1-deficient mice produces phase-shifts in peripheral clock gene expression, establishing Dec1 as an essential mediator of this non-light resetting pathway.\",\n      \"method\": \"ALK inhibitor/activator treatment, SMAD3 phosphorylation assays, Dec1-/- mouse model, in vivo clock gene expression\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in KO mice with in vivo clock resetting phenotype; high impact study\",\n      \"pmids\": [\"19029909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DEC1/STRA13 and DEC2 repress SREBP-1c by competing with SREBP-1c for binding to the E-box in the SREBP-1c promoter and/or by protein-protein interaction with SREBP-1c; DEC2 initiates acute hypoxic repression while DEC1 substitutes during prolonged hypoxia.\",\n      \"method\": \"Reporter assays, siRNA knockdown, protein-protein interaction assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two mechanisms demonstrated (DNA competition and protein interaction) with siRNA validation\",\n      \"pmids\": [\"18838394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DEC1 (BHLHB2) and DEC2 transcriptionally repress MLH1 by directly binding E-box-like motifs in the MLH1 promoter; repression is abolished by the HDAC inhibitor trichostatin A, indicating a histone deacetylase-dependent mechanism.\",\n      \"method\": \"Reporter assays, site-directed mutagenesis, EMSA, ChIP, TSA inhibition\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding confirmed by EMSA/ChIP with HDAC-mechanism validation\",\n      \"pmids\": [\"18345027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BHLHB2/DEC1 (BHLHE40) suppresses ChREBP-mediated lipogenic gene expression by binding to carbohydrate response elements (ChoRE) in the Fasn, Lpk, and Bhlhb2 promoters, forming a negative feedback loop with ChREBP.\",\n      \"method\": \"ChIP in rat hepatocytes, reporter deletion assays, overexpression studies\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct binding; single lab\",\n      \"pmids\": [\"18602890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Bhlhe40 binds to adjacent E-boxes (E1-box) on the PGC-1α core promoter and represses MyoD-mediated transactivation by sequestering the co-activator P/CAF from MyoD; P/CAF can relieve Bhlhe40-mediated repression in a dose-dependent manner.\",\n      \"method\": \"EMSA, ChIP, co-immunoprecipitation, reporter assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct DNA binding by EMSA/ChIP, interaction mechanism by Co-IP, functional rescue by P/CAF\",\n      \"pmids\": [\"19522704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dec1 (BHLHE40) interacts physically with the transcription factor Runx1 in regulatory T cells; the Dec1/Runx1 complex binds regulatory elements of the Il-2rα (CD25) locus, upregulating CD25 expression and supporting Treg homeostasis.\",\n      \"method\": \"Co-immunoprecipitation, ChIP at Il-2rα locus, enforced Dec1 expression in thymocytes\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct complex binding to target locus demonstrated by ChIP; interaction confirmed by Co-IP\",\n      \"pmids\": [\"21057086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DEC1 (BHLHE40) directly binds a DEC-response element in the cyclin D1 promoter and represses cyclin D1 expression, linking DEC1 to G1/S cell cycle control.\",\n      \"method\": \"Reporter assays with cyclin D1 promoter mutants, ChIP confirming direct binding\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding demonstrated by ChIP and mutational reporter analysis\",\n      \"pmids\": [\"21506129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DEC1 (BHLHE40) physically interacts with HDAC2 and increases binding of DEC1 to the ΔNp63 promoter when HDAC2 is knocked down; DEC1 represses ΔNp63 expression and thereby modulates keratinocyte differentiation.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, siRNA knockdown, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP demonstrates physical interaction; ChIP shows promoter occupancy with functional phenotype\",\n      \"pmids\": [\"21317427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SUMOylation of DEC1 (BHLHE40) at K159 and K279 stabilizes the protein by inhibiting ubiquitination, promotes its nuclear retention, and potentiates repression of CLOCK/BMAL1-mediated transcriptional activity through recruitment of HDAC1.\",\n      \"method\": \"SUMO modification assay in COS-7/MCF-7 cells, site-directed mutagenesis of SUMO acceptor lysines, ubiquitination assay, reporter assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — SUMOylation sites identified by mutagenesis, mechanism linked to HDAC1 recruitment and protein stability\",\n      \"pmids\": [\"21829689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SUMOylation of Stra13 (BHLHE40) at K159 and K279 potentiates transcriptional repression of cyclin D1 and G1 cell cycle arrest by enabling association with the co-repressor HDAC1; SUMO-site mutants localize normally to the nucleus but lose HDAC1 interaction and growth-suppressive activity.\",\n      \"method\": \"SUMO-site mutagenesis, co-immunoprecipitation with HDAC1, reporter assays, cell cycle analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic link between SUMOylation, HDAC1 recruitment, and cell cycle arrest established by mutagenesis and Co-IP\",\n      \"pmids\": [\"22905217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DEC1 (BHLHE40) represses PPARγ2 transcription by physically interacting with C/EBPβ already bound to the PPARγ2 promoter; DEC1 occupancy is accompanied by increased HDAC1 recruitment and reduced histone acetylation at the promoter.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, reporter assays, adipogenic differentiation assay\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and ChIP show interaction and promoter occupancy; mechanism linked to HDAC1\",\n      \"pmids\": [\"22610404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Bhlhe40 (BHLHE40) is required cell-intrinsically in T cells to positively regulate GM-CSF production and negatively regulate IL-10 production; Bhlhe40-deficient mice are resistant to EAE and IL-10 receptor blockade restores susceptibility.\",\n      \"method\": \"Bhlhe40-/- mouse model, T cell adoptive transfer, cytokine ELISA, IL-10R blockade rescue\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with cytokine rescue; in vivo and in vitro corroboration\",\n      \"pmids\": [\"24699451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DEC1 (BHLHE40) coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73: DEC1 activates TAp73 by recruiting HDAC8 to the TAp73 promoter, while repressing ΔNp73 through a distinct promoter mechanism.\",\n      \"method\": \"Co-immunoprecipitation of DEC1-HDAC8, ChIP showing HDAC8 recruitment to TAp73 promoter, reporter assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — protein interaction and differential promoter binding demonstrated by Co-IP and ChIP\",\n      \"pmids\": [\"24404147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DEC1 (BHLHE40) protein stability is regulated by a dual ubiquitin-protease mechanism: SCFβTrCP ubiquitin ligase (in cooperation with CK1) targets DEC1 for proteasomal degradation during unperturbed cell cycles, while ATM/ATR-dependent DNA damage induces rapid DEC1 stabilization via the USP17 deubiquitylase, which binds and deubiquitylates DEC1.\",\n      \"method\": \"Ubiquitination assays, protein half-life measurements, Co-IP of SCFβTrCP and USP17 with DEC1, degradation-resistant mutant expression\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro and cell-based ubiquitination/deubiquitination assays with writer (SCFβTrCP/CK1) and eraser (USP17) identified\",\n      \"pmids\": [\"25202122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Bhlhe40 (BHLHE40) functions as a cofactor of T-bet (Tbx21) on the Ifng locus in iNKT cells; Bhlhe40 accumulates at the T-box region of the Ifng locus and promotes histone H3-K9 acetylation of the Ifng locus in a T-bet-dependent manner, enhancing IFN-γ production.\",\n      \"method\": \"ChIP at Ifng locus, Bhlhe40-/- mouse model, Ifng promoter reporter assays, histone acetylation analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrates locus occupancy and histone modification; T-bet dependency shown in KO\",\n      \"pmids\": [\"27226296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BHLHE40 and BHLHE41 suppress EMT effectors SNAI1, SNAI2, and TWIST1; BHLHE40/41 compete with the transcription factor SP1 for DNA binding at the TWIST1 promoter to regulate its basal transcriptional activity.\",\n      \"method\": \"Reporter assays with TWIST1 promoter, competition binding assays, in vitro invasion assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter and competition assays; single lab\",\n      \"pmids\": [\"26391953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bhlhe40 (BHLHE40) binds directly to the PGC-1α C-terminal activation domain and co-occupies PGC-1α target gene promoters/enhancers, repressing PGC-1α transactivational activity by recruiting HDACs and preventing relief of PGC-1α intramolecular repression.\",\n      \"method\": \"Co-immunoprecipitation of Bhlhe40-PGC-1α, ChIP at target promoters, HDAC recruitment assays, siRNA knockdown\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein interaction and co-occupancy shown by Co-IP and ChIP with mechanistic follow-up\",\n      \"pmids\": [\"25963661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hypoxia induces Bhlhe40 (BHLHE40) expression via a p53-dependent but HIF1α-independent pathway; Bhlhe40 binds proximal E-boxes of the Myog promoter and reduces MyoD binding affinity and transcriptional activity, thereby inhibiting myogenic differentiation under hypoxia.\",\n      \"method\": \"Microarray analysis, ChIP at Myog promoter, Bhlhe40 overexpression/knockdown, p53-dependent pathway analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding by ChIP, mechanistic pathway placement, rescue experiment\",\n      \"pmids\": [\"26468276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DEC1 (BHLHE40) directly binds the E-box of the LKB1 promoter, repressing LKB1 expression; reduced LKB1 activity leads to decreased AMPK activity, establishing a DEC1→LKB1→AMPK regulatory axis.\",\n      \"method\": \"ChIP at LKB1 promoter E-box, DEC1 knockdown/overexpression, AMPK activity assays, DEC1 basic-domain mutants\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct binding; functional epistasis via LKB1 shown; single lab\",\n      \"pmids\": [\"26498531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IL-1β induces Bhlhe40 (BHLHE40) expression in Th17 cells, defining a PTX-IL-1β-Bhlhe40 pathway; Bhlhe40 expression identifies encephalitogenic Th cells producing IFN-γ, IL-17A, and GM-CSF, and Bhlhe40-deficient Th1 and Th17 cells are nonencephalitogenic in adoptive transfer EAE.\",\n      \"method\": \"Bhlhe40 reporter mice, adoptive transfer EAE, IL-1β stimulation, cytokine analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic reporter, adoptive transfer epistasis, and cytokine pathway placement\",\n      \"pmids\": [\"26834156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bhlhe40 (BHLHE40) positively regulates IFN-γ production and negatively regulates IL-10 production in Th1 cells; Bhlhe40-mediated IFN-γ production is independent of T-bet regulation; in vivo, Bhlhe40-deficient mice succumb to Toxoplasma gondii infection and IL-10 signaling blockade rescues them.\",\n      \"method\": \"Conditional Bhlhe40 deletion in T cells, in vitro Th1 polarization, in vivo T. gondii infection model, IL-10R blockade\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with in vivo rescue experiment establishes pathway position\",\n      \"pmids\": [\"29773643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BHLHE40 promotes HBEGF transcription by blocking DNA binding of HDAC1 and HDAC2 at the HBEGF promoter; HBEGF secreted through exosomes promotes breast cancer cell survival and migration.\",\n      \"method\": \"ChIP showing BHLHE40 at HBEGF promoter, co-immunoprecipitation of BHLHE40 with HDAC1/2, CRISPR KO, exosome analysis\",\n      \"journal\": \"Breast cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and Co-IP with CRISPR validation and functional cellular assays\",\n      \"pmids\": [\"30285805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bhlhe40 (BHLHE40) negatively regulates PGC-1α gene expression and the function and biogenesis of peroxisomes and mitochondria in myogenic cells; Bhlhe40 knockdown increases peroxisome number/activity but reduces mitochondrial efficiency, while overexpression of the PGC-1α-interacting domain of Bhlhe40 differentially regulates the two organelles.\",\n      \"method\": \"siRNA knockdown, overexpression, peroxisome/mitochondria counting and activity assays, gene expression profiling\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular phenotype with organelle-level readouts; single lab\",\n      \"pmids\": [\"30391825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DEC1 (BHLHE40) and CLOCK bind E-boxes in the ATP1B1 (Na+/K+-ATPase β1 subunit) promoter; CLOCK:BMAL1 activates ATP1B1 transcription while DEC1 suppresses this transactivation, and Dec1-deficient mice show enhanced Atp1b1 expression and reduced blood pressure.\",\n      \"method\": \"ChIP and ChIP-on-chip at ATP1B1 promoter, luciferase reporter assays, Dec1-/- and Clock-mutant mice\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding by ChIP confirmed by KO phenotype in vivo\",\n      \"pmids\": [\"30012868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bhlhe40 (BHLHE40) is required for tissue-resident memory CD8+ T cell (Trm) and tumor-infiltrating lymphocyte (TIL) development and polyfunctionality; mechanistically, Bhlhe40 sustains mitochondrial fitness and a functional epigenetic state; local PD-1 signaling inhibits TIL Bhlhe40 expression and Bhlhe40 is critical for TIL reinvigoration following anti-PD-L1 blockade.\",\n      \"method\": \"Bhlhe40 KO mouse model, mitochondrial function assays, ATAC-seq epigenetic profiling, anti-PD-L1 treatment\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (metabolic, epigenetic, genetic KO, checkpoint blockade) in single high-impact study\",\n      \"pmids\": [\"31533057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bhlhe40 (BHLHE40) is required cell-intrinsically for the self-renewal and proliferation (but not polarization) of large peritoneal macrophages (LPMs); Bhlhe40 represses c-Maf and Mafb expression and directly promotes expression of cell cycle genes; Bhlhe40 binds genomic sites co-occupied by PU.1 as well as unique sites at Maf and cell-cycle loci.\",\n      \"method\": \"Bhlhe40 conditional KO, competitive reconstitution, ChIP-seq in LPMs, IL-4 proliferation assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq plus genetic KO with defined proliferation phenotype\",\n      \"pmids\": [\"31061528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bhlhe40 and Bhlhe41 directly repress expression of lineage-inappropriate genes in alveolar macrophages (AMs) to maintain AM identity and self-renewal; genome-wide Bhlhe40 DNA binding analysis showed direct repression of non-AM signature genes.\",\n      \"method\": \"Bhlhe40/41 double-KO mouse model, gene expression analysis, ChIP-seq/genome-wide binding characterization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide binding data combined with functional KO phenotype\",\n      \"pmids\": [\"31414712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BHLHE40 expression in H. pylori-infected gastric epithelial cells is induced via the cagA-ERK pathway; BHLHE40 translocates to the nucleus and binds p-STAT3 (Tyr705); the BHLHE40-p-STAT3 complex increases CXCL12 expression, fostering CD4+ T cell infiltration.\",\n      \"method\": \"Co-immunoprecipitation of BHLHE40 and p-STAT3, ChIP at CXCL12 promoter, ERK pathway inhibitors\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and ChIP demonstrate interaction and functional outcome; single lab\",\n      \"pmids\": [\"31914631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BHLHE40 (and BHLHE41) act as negative feedback regulators of TFEB transcriptional activity; high, sustained nuclear TFEB induces BHLHE40/41 expression, and BHLHE40/41 counter-regulate TFEB target genes, particularly genes relevant to lysosomal cell death.\",\n      \"method\": \"Genome-wide CRISPR screen, TFEB activation assays, gene expression analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR screen plus functional validation; single study\",\n      \"pmids\": [\"33176151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BHLHE40 is required in T cells for a TH2 cell transcriptional program during helminth infection, positively regulating GM-CSF (Csf2) and IL-5 production; combined loss of GM-CSF and IL-5 signaling impairs helminth protection.\",\n      \"method\": \"Bhlhe40 conditional KO in T cells, helminth infection model, cytokine gene expression analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional KO with cytokine redundancy demonstrated; single lab\",\n      \"pmids\": [\"31900338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Bhlhe40 (BHLHE40) is a cell-intrinsic negative regulator of the germinal center (GC) reaction; in activated CD4 T cells it restrains proliferation limiting TFH numbers, while in B cells it selectively restricts generation of earliest GC B cells; Bhlhe40-deficient mice develop B cell lymphoma characterized by GC B-like cells.\",\n      \"method\": \"Bhlhe40-/- mouse model, flow cytometry, adoptive transfer, longitudinal lymphoma monitoring\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined cellular and disease phenotype\",\n      \"pmids\": [\"34919144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BHLHE40 directly transcriptionally regulates TAN-1 (pro-tumour neutrophil) marker genes in pancreatic cancer, downstream of hypoxia and endoplasmic reticulum stress; direct transcriptional regulation demonstrated by ChIP assay.\",\n      \"method\": \"Single-cell RNA-seq, ChIP assay, BHLHE40 overexpression in dHL-60 cells\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct regulation; functional overexpression data; single study\",\n      \"pmids\": [\"35688610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BHLHE40 regulates T cell-dependent anti-tumor immunity and immune checkpoint therapy (ICT) efficacy; anti-PD-1 and anti-CTLA-4 upregulate BHLHE40 in tumor antigen-specific T cells; BHLHE40-deficient T cells show dysregulated NF-κB signaling, IFNγ response, and altered chemokine/granzyme expression; BHLHE40 is required for ICT-driven macrophage polarization.\",\n      \"method\": \"Bhlhe40-/- mouse model, single-cell RNA-seq, in vivo tumor models with ICT\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO combined with scRNA-seq; single study\",\n      \"pmids\": [\"35181783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BHLHE40 regulates SREBF1 transcription as a classic transcription factor and also physically links the enhancer and promoter regions of SREBF1; the BHLHE40-SREBF1-stearoyl-CoA desaturase axis protects pancreatic cancer cells from ferroptosis by reducing lipid peroxidation.\",\n      \"method\": \"ChIP-seq, RNA-seq, Hi-C/chromosome conformation capture assays, BHLHE40 KO/overexpression\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multi-omics including ChIP-seq and 3D genome conformation data with functional ferroptosis readout\",\n      \"pmids\": [\"38064101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BHLHE40 (BHLHE40) in vitro CRISPR screen identified it as a regulator of CD8+ T cell exhaustion differentiation; in vitro and in vivo validation showed BHLHE40 regulates the differentiation checkpoint between progenitor and intermediate exhausted T cell subsets.\",\n      \"method\": \"In vitro chronic stimulation model, genome-wide CRISPR screen, in vivo validation\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR screen with in vivo validation; single study\",\n      \"pmids\": [\"37595022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BHLHE40 represses MAFA expression by attenuating the binding of PDX1 to the Mafa enhancer region, thereby suppressing insulin secretion in hypoxic β-cells; BHLHE40 deficiency in hypoxic MIN6 cells or ob/ob β-cells reverses insulin secretion defects.\",\n      \"method\": \"BHLHE40 KO/overexpression in MIN6 cells and ob/ob mice, ChIP at Mafa enhancer, MAFA re-expression rescue\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP shows mechanism (reduced PDX1 binding), genetic rescue with MAFA re-expression, in vivo ob/ob model\",\n      \"pmids\": [\"37341148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Loss of BHLHE40/41 in macrophages results in increased expression of DLAM (disease-associated macrophage) genes involved in cholesterol clearance and lysosomal processing, increased cholesterol efflux and storage, and increased lysosomal mass and degradative capacity, identifying BHLHE40/41 as transcriptional repressors of this activation state.\",\n      \"method\": \"BHLHE40/41 KO in iPSC-derived microglia and THP-1 macrophages; mouse Bhlhe40/41 KO; gene regulatory network reconstruction from scRNA-seq data\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell models (iPSC-microglia, THP-1, mouse KO) with functional lipid/lysosomal readouts\",\n      \"pmids\": [\"38448474\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BHLHE40 is a bHLH transcriptional repressor (and context-dependent activator) that competes with CLOCK:BMAL1 and other bHLH factors for E-box binding to regulate circadian rhythms, hypoxia responses, and immune cell function; its activity is modulated by SUMOylation (which recruits HDAC1/2 and stabilizes the protein), ubiquitin-mediated proteolysis (SCFβTrCP/CK1 for degradation, USP17 for stabilization after DNA damage), and protein-protein interactions with STAT3, Runx1, PGC-1α, T-bet, USF, MSP58, and HDAC1/2/8, collectively enabling it to control cytokine production (GM-CSF, IFN-γ, IL-10), macrophage identity/proliferation, T cell exhaustion checkpoints, mitochondrial fitness, lipid metabolism, and cellular senescence.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BHLHE40 is a basic helix-loop-helix transcriptional repressor—and context-dependent activator—that integrates circadian, hypoxic, and immune signals to control gene expression programs governing cell proliferation, differentiation, and inflammatory responses. It represses target genes primarily by competing with CLOCK:BMAL1 and other bHLH/bHLHZip factors (USF, ChREBP, SREBP-1c, SP1) for E-box binding and by recruiting HDAC1/2 to promoters, with SUMOylation at K159/K279 stabilizing the protein and potentiating HDAC1-dependent repression [PMID:9284045, PMID:21829689, PMID:22905217, PMID:14581485, PMID:18838394]. In immune cells, BHLHE40 is required cell-intrinsically for GM-CSF and IFN-γ production, IL-10 suppression, macrophage self-renewal, germinal center restraint, and CD8+ T cell exhaustion checkpoint control; its loss renders T cells nonencephalitogenic and impairs anti-tumor immunity and checkpoint-blockade responses [PMID:24699451, PMID:29773643, PMID:31061528, PMID:31533057, PMID:37595022]. BHLHE40 protein stability is governed by SCFβTrCP/CK1-mediated ubiquitination driving degradation and USP17-mediated deubiquitination stabilizing it after DNA damage, while interactions with p53, STAT3, T-bet, Runx1, and PGC-1α direct its activity toward specific gene programs including apoptosis, cytokine regulation, and mitochondrial/metabolic control [PMID:25202122, PMID:17347673, PMID:15223310, PMID:27226296, PMID:25963661].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that BHLHE40 is a bHLH transcriptional repressor that acts through its α-helix-rich C-terminal domain rather than through canonical E-box binding defined the gene's foundational molecular identity.\",\n      \"evidence\": \"Transient transfection reporter assays and protein-protein interaction studies in P19 cells\",\n      \"pmids\": [\"9284045\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No endogenous target genes identified\", \"Mechanism of repression (direct vs. cofactor-mediated) unresolved\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that BHLHE40 physically antagonizes USF via its C-terminal domain and that Bhlhe40-knockout mice develop autoimmunity with lymphocyte accumulation revealed both a bHLH-factor competition mechanism and an essential in vivo role in immune homeostasis.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation, and reporter assays for USF interaction; Stra13-KO mouse model with lymphocyte phenotyping\",\n      \"pmids\": [\"11498797\", \"11668339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in T cells unknown\", \"Whether immune phenotype reflects repressor or activator function unclear\", \"Redundancy with BHLHE41 not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of HIF-1α/β binding to the BHLHE40 promoter HRE placed BHLHE40 as a direct hypoxia-responsive gene, establishing its role as a transcriptional effector linking oxygen sensing to downstream gene regulation.\",\n      \"evidence\": \"Luciferase reporters, EMSA with HIF-1α/β, deletion/mutation analysis of HRE\",\n      \"pmids\": [\"12354771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hypoxia-regulated target genes of BHLHE40 not yet catalogued\", \"Relationship between hypoxia and circadian functions not integrated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that CLOCK:BMAL1 drives circadian BHLHE40 expression and that BHLHE40 represses its own promoter via E-box binding established BHLHE40 as an autoregulatory component of the peripheral circadian clock.\",\n      \"evidence\": \"Reporter assays and microarray in Stra13−/− mouse liver; DEC1-DEC2 cross-repression via E-box mutagenesis\",\n      \"pmids\": [\"14581485\", \"12624110\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BHLHE40 is essential for core clock function or only modulatory\", \"Redundancy with DEC2/CRY in clock repression not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Dissecting that BHLHE40 represses mPer1 through direct E-box DNA binding rather than through protein-protein interaction with BMAL1 resolved the primary repression mechanism in the clock circuit, while identification of STAT3 interaction revealed a non-E-box co-regulatory mode.\",\n      \"evidence\": \"DNA-binding mutant analysis for mPer1 repression; yeast two-hybrid and co-IP for STAT3 interaction with functional reporter assays\",\n      \"pmids\": [\"15193144\", \"15223310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide binding profile not available\", \"STAT3 interaction not validated in vivo\", \"Whether E-box-dependent and STAT3-dependent functions operate in the same cell types unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that BHLHE40 recruits HDAC1 via its C-terminal domain to repress STAT1 and that it activates the survivin promoter through Sp1 sites established HDAC-dependent repression and context-dependent activation as dual modes of action.\",\n      \"evidence\": \"ChIP, TSA inhibition, Sp1-site mutagenesis, and EMSA at survivin and STAT1 promoters\",\n      \"pmids\": [\"16878149\", \"16462771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full HDAC family involvement not mapped\", \"Structural basis for context-dependent activation vs. repression unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that BHLHE40 stabilizes p53 by blocking Mdm2-mediated ubiquitination and that p53 reciprocally induces BHLHE40 transcription defined a positive-feedback circuit coupling DNA damage to apoptosis and senescence; separately, BHLHE40 was shown to antagonize Notch signaling in satellite cells and to promote TGF-β-dependent metastatic survival.\",\n      \"evidence\": \"Stra13−/− thymocytes with reduced p53/Puma/Noxa after irradiation; in vitro ubiquitination assays; Notch rescue in KO myoblasts; dominant-negative DEC1 in metastasis model\",\n      \"pmids\": [\"18025081\", \"17347673\", \"17502421\", \"17942899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct p53-binding domain on BHLHE40 not mapped\", \"Whether Notch antagonism is direct or transcriptional unclear\", \"TGF-β survival mechanism not fully defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"A series of studies identified endogenous BHLHE40 target promoters (BDNF exon 4, MLH1, SREBP-1c, ChREBP targets, ATP1B1) repressed through E-box binding and HDAC-dependent mechanisms, and showed TGF-β/SMAD3-dependent induction of BHLHE40 mediates non-photic circadian clock resetting in vivo.\",\n      \"evidence\": \"EMSA/ChIP in hippocampal neurons and hepatocytes; Bhlhe40−/− mice for BDNF and clock resetting; TSA rescue for MLH1; Dec1−/− mice with TGF-β injection\",\n      \"pmids\": [\"18234890\", \"18345027\", \"18838394\", \"18602890\", \"19029909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target repertoire still lacking\", \"Tissue-specific vs. universal targets not distinguished\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of SUMOylation at K159/K279 as a stabilizing modification that promotes nuclear retention, HDAC1 recruitment, and enhanced CLOCK:BMAL1 repression provided the first post-translational regulatory code for BHLHE40 activity.\",\n      \"evidence\": \"SUMO modification assays, site-directed mutagenesis, ubiquitination assays, reporter assays in COS-7/MCF-7 cells\",\n      \"pmids\": [\"21829689\", \"22905217\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SUMO E3 ligase responsible not identified\", \"In vivo relevance of SUMOylation not tested\", \"Interplay between SUMOylation and ubiquitination pathways not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defining BHLHE40 as a cell-intrinsic regulator of GM-CSF and IL-10 in T cells, identifying the SCFβTrCP/CK1-dependent degradation and USP17-dependent stabilization axis, and showing BHLHE40 co-activates IFN-γ with T-bet at the Ifng locus established its immune effector function and protein turnover control.\",\n      \"evidence\": \"Bhlhe40−/− EAE model with IL-10R blockade rescue; Co-IP of SCFβTrCP and USP17 with ubiquitination assays; ChIP at Ifng locus with histone acetylation analysis\",\n      \"pmids\": [\"24699451\", \"25202122\", \"27226296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether T-bet-dependent and -independent IFN-γ regulation co-occur in same T cell subsets\", \"CK1 phosphorylation sites on BHLHE40 not fully mapped\", \"USP17 regulation in immune cells unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing that BHLHE40 directly binds and represses PGC-1α transactivation by recruiting HDACs and preventing relief of PGC-1α intramolecular repression established BHLHE40 as a metabolic corepressor controlling mitochondrial gene programs.\",\n      \"evidence\": \"Co-immunoprecipitation of Bhlhe40-PGC-1α, ChIP at target promoters, HDAC recruitment assays, siRNA knockdown\",\n      \"pmids\": [\"25963661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo metabolic phenotype of Bhlhe40 KO not fully characterized\", \"Peroxisome vs. mitochondria specificity mechanism unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genome-wide binding studies and functional genetics revealed BHLHE40 sustains mitochondrial fitness and epigenetic openness in tissue-resident memory and tumor-infiltrating CD8+ T cells, controls macrophage self-renewal by repressing Maf family genes, and maintains alveolar macrophage identity—establishing BHLHE40 as a master regulator of immune cell fitness and identity.\",\n      \"evidence\": \"ChIP-seq in peritoneal and alveolar macrophages; ATAC-seq in TILs; conditional KO with anti-PD-L1 treatment; Bhlhe40/41 double-KO\",\n      \"pmids\": [\"31533057\", \"31061528\", \"31414712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets mediating mitochondrial fitness in T cells not defined\", \"Whether macrophage and T cell programs share common BHLHE40 target genes\", \"BHLHE40 vs. BHLHE41 functional redundancy quantitatively unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CRISPR screens and in vivo models placed BHLHE40 at the differentiation checkpoint between progenitor and intermediate exhausted CD8+ T cells and showed it is required for effective anti-PD-1/anti-CTLA-4 immunotherapy responses, linking its transcriptional program to clinical checkpoint blockade efficacy.\",\n      \"evidence\": \"Genome-wide CRISPR screen with chronic stimulation model; Bhlhe40−/− tumor models with ICT; scRNA-seq\",\n      \"pmids\": [\"37595022\", \"35181783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct gene targets at the exhaustion checkpoint not mapped by ChIP\", \"Human patient validation limited\", \"Whether BHLHE40 is therapeutically targetable\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Multi-omics approaches revealed that BHLHE40 physically mediates enhancer-promoter looping at the SREBF1 locus to regulate lipid desaturation and ferroptosis resistance, and represses MAFA via displacement of PDX1 to suppress insulin secretion in hypoxic β-cells, expanding its mechanistic repertoire to 3D genome organization and metabolic disease.\",\n      \"evidence\": \"ChIP-seq, Hi-C/chromosome conformation capture at SREBF1; ChIP at Mafa enhancer in MIN6 cells and ob/ob mice with rescue\",\n      \"pmids\": [\"38064101\", \"37341148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide enhancer-promoter bridging role not assessed beyond SREBF1\", \"Structural basis for chromatin looping activity unknown\", \"β-cell findings not validated in human islets\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that BHLHE40/41 loss in macrophages de-represses disease-associated macrophage (DLAM) genes governing cholesterol efflux and lysosomal processing established BHLHE40 as a gatekeeper of macrophage activation states relevant to neurodegeneration and atherosclerosis.\",\n      \"evidence\": \"BHLHE40/41 KO in iPSC-derived microglia, THP-1, and mouse models; scRNA-seq gene regulatory network reconstruction; lipid/lysosomal functional assays\",\n      \"pmids\": [\"38448474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo disease model validation (e.g., atherosclerosis, Alzheimer's) not performed\", \"Whether therapeutic de-repression of DLAM is beneficial or detrimental long-term\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Despite extensive characterization, the structural basis for BHLHE40's dual repressor/activator activity, its genome-wide binding landscape across immune cell states, the full extent of BHLHE40-BHLHE41 functional redundancy, and whether BHLHE40 can be therapeutically modulated in cancer immunotherapy or metabolic disease remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of BHLHE40 or its complexes\", \"Systematic comparison of BHLHE40 vs. BHLHE41 ChIP-seq across cell types lacking\", \"No pharmacological tool compounds reported\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 7, 16, 18, 19, 20, 21, 23, 34, 35, 50]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 5, 6, 10, 11, 25, 26, 27, 33, 42, 43, 50]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [13, 33, 45]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 25, 44]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 5, 6, 10, 11, 25, 26, 27, 33, 42, 43, 50]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [6, 7, 17, 40]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 28, 36, 37, 41, 42, 46, 47, 49, 51, 53]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3, 10, 18, 34, 52]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [25, 26, 31]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [12, 23, 26, 42]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [18, 20, 50, 53]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 14, 15, 44, 45]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"HDAC1\",\n      \"HDAC2\",\n      \"STAT3\",\n      \"USF1\",\n      \"PGC1A\",\n      \"RUNX1\",\n      \"TBX21\",\n      \"TP53\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}